1Simonneau G,Barst RJ,Galie N,et al.Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial[].American Journal of Respiratory and Critical Care Medicine.2002
2Hoeper MM.Pulmonary hypertension in collagen vascular disease[].European Respiratory Journal.2002
3McLaughlin VV,Gaine SP,Barst RJ,at al.Efficacy and safety of treprostinil: an epoprostenol analog for primary pulmonary hypertension[].Journal of Cardiovascular Pharmacology.2003
4Cea-Calvo L,Escribano Subias P,Tello de Menesses R,et al.Treatment of HIV-associated pulmonary hypertension with treprostinil[].Revista Espanola de Cardiologia.2003
5Widlitz A,Barst RJ.Pulmonary arterial hypertension in children[].European Respiratory Journal.2003
6Maloney JP.Advances in the treatment of secondary pulmonary hypertension[].Current Opinion in Pulmonary Medicine.2003
7Moller ER 3rd,Klugherz B,Goldman R,et al.Trial of a novel prostacyclin analog, UT-15, in patients with severe intermittent claudication[].Vascular Medicine.2000
8Wade M,Hunt TL,Lai AA.Effect of continuous subcutaneous treprostinil therapy on the pharma codynamics and pharmacokinetics of warfarin[].Journal of Cardiovascular Pharmacology.2003
9Vachiery JL,Hill N,Zwicke D,et al.Transitioning from i.v. epoprostenol to subcutaneous treprostinil in pulmonary arterial hypertension[].Chest.2002
同被引文献7
1Barrington K, Finer N. Inhaled nitric oxide for respiratory failure inpreterm infants [J]. Cochrane Database Syst Rev,2011,8(12) :509.
2Nathan SD. Hypersensitivity pneumonitis and pulmonary hypertension: how the breeze affects the squeeze[J ]. Eur Respir J ,2014,44(2) :287 - 288.
